Australia markets closed

Atara Biotherapeutics, Inc. (ATRA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.6700+0.0197 (+3.03%)
At close: 04:00PM EDT
0.6848 +0.01 (+2.21%)
After hours: 06:49PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 79.97M
Enterprise value 86.12M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)8.28
Price/book (mrq)N/A
Enterprise value/revenue 10.05
Enterprise value/EBITDA -0.32

Trading information

Stock price history

Beta (5Y monthly) 0.72
52-week change 3-78.11%
S&P500 52-week change 322.38%
52-week high 33.0150
52-week low 30.1990
50-day moving average 30.7086
200-day moving average 31.0523

Share statistics

Avg vol (3-month) 31.93M
Avg vol (10-day) 31.04M
Shares outstanding 5119.36M
Implied shares outstanding 6119.36M
Float 890.82M
% held by insiders 12.77%
% held by institutions 159.78%
Shares short (15 Apr 2024) 411.45M
Short ratio (15 Apr 2024) 49.11
Short % of float (15 Apr 2024) 49.80%
Short % of shares outstanding (15 Apr 2024) 49.59%
Shares short (prior month 15 Mar 2024) 411.03M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,922.44%

Management effectiveness

Return on assets (ttm)-62.11%
Return on equity (ttm)-2,014.86%

Income statement

Revenue (ttm)8.57M
Revenue per share (ttm)0.08
Quarterly revenue growth (yoy)1,345.70%
Gross profit (ttm)N/A
EBITDA -264.45M
Net income avi to common (ttm)-276.13M
Diluted EPS (ttm)-2.6100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)51.73M
Total cash per share (mrq)0.43
Total debt (mrq)60.49M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.72
Book value per share (mrq)-0.93

Cash flow statement

Operating cash flow (ttm)-192.98M
Levered free cash flow (ttm)-55.72M